Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase PfCLK3 is an essential regulator of RNA splicing required for malaria parasite viability at multiple life stages—including blood, liver, and sexual forms—and represents a highly promising target for next-generation antimalarials with both treatment and transmission-blocking capabilities.
Inhibition of PfCLK3 leads to impaired phosphorylation of SR proteins, disrupted mRNA processing/splicing, and downregulation of essential genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase Plasmodium falciparum CLK3 (PfCLK3).